In harmony with this, phytochemicals can enhance the susceptibility of cancer cells and animal tumor models to anticancer treatments by interfering with many processes, such as cell cycle arrest, DNA damage, angiogenesis, and variant signaling pathways, especially TLR/NF-κB/NLRP [18]. This evidence concerns the gene NFKB1 and neoplasm.